Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 06, 2026 3.688
October 05, 2026 3.772
October 02, 2026 3.889
October 01, 2026 3.982
September 30, 2026 4.091
September 29, 2026 4.192
September 28, 2026 4.192
September 25, 2026 3.923
September 24, 2026 4.024
September 23, 2026 4.124
September 22, 2026 4.334
September 21, 2026 4.234
September 18, 2026 4.217
September 17, 2026 4.334
September 16, 2026 4.259
September 15, 2026 4.250
September 14, 2026 4.208
September 11, 2026 4.217
September 10, 2026 4.334
September 09, 2026 4.486
September 08, 2026 4.603
September 04, 2026 4.704
September 03, 2026 4.679
September 02, 2026 4.738
September 01, 2026 4.788
Date Value
August 31, 2026 4.780
August 28, 2026 4.847
August 27, 2026 5.006
August 26, 2026 5.057
August 25, 2026 5.208
August 24, 2026 5.015
August 21, 2026 5.116
August 20, 2026 5.132
August 19, 2026 5.401
August 18, 2026 5.200
August 17, 2026 5.216
August 14, 2026 4.998
August 13, 2026 5.032
August 12, 2026 5.380
August 11, 2026 5.611
August 10, 2026 5.351
August 07, 2026 5.510
August 06, 2026 5.326
August 05, 2026 5.426
August 04, 2026 5.208
August 03, 2026 4.855
July 31, 2026 4.922
July 30, 2026 4.935
July 29, 2026 4.712
July 28, 2026 4.586

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Altimmune, Inc. 1.093
Protalix Biotherapeutics, Inc. 3.064
Humacyte, Inc. 4.216
Agenus, Inc. --
Amgen, Inc. 19.10

Price to Book Value Related Metrics

PS Ratio 278.38
PEG Ratio -0.4875
Price 4.445
Earnings Yield -9.73%
Market Cap 1.446B
PEGY Ratio -0.4875